Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ANVS

Annovis Bio Inc

May 27 • 04:00PM ET

2.01

-0.05 -2.43 %

Healthcare • Biotechnology • USA • Micro • NYSE

Peers: ANIX ATYR COYA CYPH EXOZ FBIO ICCC INO MCRB XBIT

| Held by: VTI VXF DFAS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.72	Insider Own	8.06%	Shs Outstand	34.65M	Perf Week	3.61%
Market Cap	69.64M	Forward P/E	-	EPS next Y	-1.22	Insider Trans	42.67%	Shs Float	31.85M	Perf Month	6.35%
Enterprise Value	55.42M	PEG	-	EPS next Q	-0.41	Inst Own	16.52%	Short Float	15.12%	Perf Quarter	-30.21%
Income	-40.92M	P/S	-	EPS this Y	-14.29%	Inst Trans	2.75%	Short Ratio	4.87	Perf Half Y	-46.97%
Sales	0.00M	P/B	18.35	EPS next Y	23.75%	ROA	-190.43%	Short Interest	4.82M	Perf YTD	-41.91%
Book/sh	0.11	P/C	4.90	EPS next 5Y	-4.66%	ROE	-301.13%	52W High	5.50 -63.45%	Perf Year	-1.47%
Cash/sh	0.41	P/FCF	-	EPS past 3/5Y	23.23% -10.15%	ROIC	-1309.11%	52W Low	1.54 30.46%	Perf 3Y	-84.99%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	11.94% 8.64%	Perf 5Y	-95.49%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	20.55%	Oper. Margin	-	ATR (14)	0.19	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.27	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	46.06	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.27	EPS Q/Q	-99.06%	SMA20	-6.21%	Beta	1.30	Target Price	12.50
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-4.37%	Rel Volume	1.19	Prev Close	2.06
Employees	8	LT Debt/Eq	0.00	Earnings	May 15 BMO	SMA200	-23.35%	Avg Volume	988.26K	Price	2.01
IPO	Jan 29, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-59.49% -	Trades		Volume	1,177,939	Change	-2.43%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)